Stay updated on GB001 in Chronic Rhinosinusitis Clinical Trial
Sign up to get notified when there's something new on the GB001 in Chronic Rhinosinusitis Clinical Trial page.

Latest updates to the GB001 in Chronic Rhinosinusitis Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a consolidated Locations section listing study sites across multiple states and countries (Arizona, Arkansas, California, Connecticut, Georgia, Illinois, Iowa, Kentucky, Louisiana, Maryland, Massachusetts, Nebraska, New Mexico, New York, Oklahoma, Pennsylvania, South Carolina, Texas, Virginia) and updated to Revision: v3.3.3. Removed prior state-specific location subsections and the HHS Vulnerability Disclosure.SummaryDifference2%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedFooter revision updated from v3.2.0 to v3.3.2; study details, eligibility criteria, and locations appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check49 days agoChange DetectedThe government funding lapse notice is removed from the page; all study details, locations, and contacts remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check64 days agoChange DetectedThe Study Details page appears redesigned with reorganized sections and updated formatting, but the core content (study design, primary/secondary outcomes, eligibility criteria, and locations) remains unchanged.SummaryDifference0.4%

- Check92 days agoChange DetectedIntroducing a government funding status notice and a new version tag v3.2.0, replacing v3.1.0.SummaryDifference3%

- Check100 days agoChange DetectedNew version tag v3.1.0 added and several MedlinePlus topics removed (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs); older version tag v3.0.2 removed. Core page content and topic scope updated accordingly.SummaryDifference0.5%

Stay in the know with updates to GB001 in Chronic Rhinosinusitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GB001 in Chronic Rhinosinusitis Clinical Trial page.